A Randomized Phase III Study Comparing Maintenance Pemetrexed Therapy After Induction Chemotherapy Versus Pemetrexed at Progression in Advanced Non-Small-Cell Lung Cancer [Randomisert fase III studie som sammenlikner vedlikeholdsbehandling med pemetrexed mot pemetrexed-behandling ved progresjon hos pasienter med avansert ikke-småcellet lungecancer etter induksjons kjemoterapi.]

Trial Profile

A Randomized Phase III Study Comparing Maintenance Pemetrexed Therapy After Induction Chemotherapy Versus Pemetrexed at Progression in Advanced Non-Small-Cell Lung Cancer [Randomisert fase III studie som sammenlikner vedlikeholdsbehandling med pemetrexed mot pemetrexed-behandling ved progresjon hos pasienter med avansert ikke-småcellet lungecancer etter induksjons kjemoterapi.]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2014

At a glance

  • Drugs Pemetrexed (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Dec 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 10 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top